Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eumedica pharmaceuticals gmbh - somatostatin acetate hydrate - eq. somatostatin 6 mg - powder and solvent for solution for injection/infusion - 6 mg - somatostatin acetate hydrate - somatostatin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eumedica pharmaceuticals gmbh - somatostatin acetate hydrate - eq. somatostatin 250 µg - powder and solvent for solution for injection - 250 µg - somatostatin acetate hydrate - somatostatin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eumedica pharmaceuticals gmbh - somatostatin acetate hydrate - eq. somatostatin 3 mg - powder and solvent for solution for infusion - 3 mg - somatostatin acetate hydrate - somatostatin

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wael pharmacy - somatostatin acetate hydrate - powder & solvent for injectable solution - 250

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wael pharmacy - somatostatin acetate hydrate - powder & solvent for injectable solution - 3

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

somatostatin acetate hydrated -

Singapore - English - HSA (Health Sciences Authority)

a. menarini singapore pte. ltd. - somatostatin acetate hydrate eqv somatostatin - injection, powder, for solution - 3 mg/vial

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eumedica sa-nv - somatostatin 3 mg - powder and solvent for solution for infusion - 3 mg - somatostatin 3 mg - somatostatin

Malta - English - Malta Medicines Authority

inresa arzneimittel gmbh obere hardtstrasse 18, 79114 freiburg, germany - somatostatin - powder for solution for infusion - somatostatin 3 mg - pituitary and hypothalamic hormones and analogues

United States - English - NLM (National Library of Medicine)

wockhardt limited - octreotide acetate (unii: 75r0u2568i) (octreotide - unii:rwm8ccw8gp) - octreotide 50 ug in 1 ml - octreotide acetate injection is indicated to reduce blood levels of growth hormone and igf-i (somatomedin c) in acromegaly patients who have had inadequate response to or cannot be treated with surgical resection, pituitary irradiation, and bromocriptine mesylate at maximally tolerated doses. the goal is to achieve normalization of growth hormone and igf-i (somatomedin c) levels (see dosage and administration). in patients with acromegaly, octreotide acetate reduces growth hormone to within normal ranges in 50% of patients and reduces igf-i (somatomedin c) to within normal ranges in 50%-60% of patients. since the effects of pituitary irradiation may not become maximal for several years, adjunctive therapy with octreotide acetate to reduce blood levels of growth hormone and igf-i (somatomedin c) offers potential benefit before the effects of irradiation are manifested. improvement in clinical signs and symptoms or reduction in tumor size or rate of growth were not shown in clinical trials performed with octre